Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating drug-eluting stents in everyday clinical practice

Official title: Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice

Run by Asan Medical Center · NCT01788592 · Data updated 2026-11-12

This study is testing how well drug-eluting stents work and their safety for people with coronary artery disease in everyday medical settings.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50000 (estimated)
SponsorAsan Medical Center
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedJanuary 2003
Main results expectedOctober 2030
Study endsOctober 2030
Registry record updatedJanuary 2, 2026
Trial IDNCT01788592 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with coronary artery disease who are eligible for percutaneous coronary intervention without any clinical or lesion limitations.

Probably not a fit

Patients with terminal illnesses, those experiencing cardiogenic shock, or those requiring a mix of different drug-eluting stents may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness and safety of drug-eluting stent implantation for patients with coronary artery disease in routine clinical settings. By observing real-world outcomes, the study seeks to provide insights into how these stents perform outside of controlled trial environments. The observational nature of the study allows for a comprehensive evaluation of patient responses and potential complications associated with the stents.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of drug-eluting stents' effectiveness, leading to improved treatment strategies for coronary artery disease.

How similar studies have gone: Other studies evaluating drug-eluting stents in real-world settings have shown promising results, indicating that this approach is supported by previous findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* coronary disease amenable to percutaneous coronary intervention (PCI)
* no clinical and lesion limitations

Exclusion Criteria:

* patients with a mixture of several drug eluting stents
* terminal illness with life expectancy less than 1 year
* patients with cardiogenic shock

Where it's running

  • Asan Medical Center
    Seoul, South Korea
    Recruiting

Study contacts

  • Principal investigator: Seung-Jung Park, MD, PhD — Asan Medical Center

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.